Drawing for SPATIAL PATHOLOGY POWERS PRECISION THERAPEUTICS

USPTO serial 97059511

SPATIAL PATHOLOGY POWERS PRECISION THERAPEUTICS

Reviewed by CopyMark Law Group

Status 606
Filing date
Status date
Registration date
—
Examiner
MAI, TINA HSIN
Law office
INTENT TO USE SECTION

What this means

This page summarizes the public USPTO record for this serial number, including owners, goods and services, and prosecution history.

Need help with SPATIAL PATHOLOGY POWERS PRECISION THERAPEUTICS?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

Victoria D Summerfield

Victoria D Summerfield TROUTMAN PEPPER HAMILTON SANDERS LLP501 GRANT STREET, SUITE 300, UNION TRUSTPITTSBURGH, PA 15219United States

Goods and services

ClassDescriptionStatusFirst use
042Software as a service (SAAS) services featuring web based pathology software, namely, web based image analysis that defines the spatial relationships between cells and molecules within tissue microenvironments to aid in the interpretation of patient tissue samples; SAAS services featuring software for performing image analysis in the field of pathology, namely, in connection with transmitted light microscopy and fluorescence microscopy; SAAS services featuring software for viewing and managing images and for digital pathology image management; SAAS services featuring software for use in cancer diagnosis, namely, software to predict metastatic potential in primary solid tumors; SAAS services featuring web based software for viewing, annotating, analyzing, and scoring digital slides, for consolidating case information, a score, results, a diagnosis, comments, and digital images into a pathology case report, for generating, exporting, and printing pathology case reports, and for providing audit trails in the field of pathology; SAAS services featuring web based software for remotely managing pathology images, for remotely managing pathology images and metadata, and for creating, assigning, and managing pathology cases; providing an online searchable database of images for evaluating machine learning algorithms for computational pathology, for scientific research purposes and medical research purposes; medical research, namely, pathology evaluations utilizing image analysis algorithms; medical and scientific research and consultation in the field of cancer treatment and diagnosis; medical and scientific research and consultation in the field of medical imaging; SAAS services featuring computer software for use in image analysis of digital images of tissue samples acquired by optical microscopy; SAAS services featuring computer software for creating tissue-based image analysis algorithms; and SAAS services featuring data-processing software for tissue-based image analysis using algorithmsACTIVE—

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

Latest event (MAB6): The intent-to-use application was abandoned because no acceptable Statement of Use (or valid extension) was filed before the Notice of Allowance deadline expired. The application is dead unless revived within a limited window.

DateCodeEventWhat it means
Dec 8, 2025MAB6ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILEDThe intent-to-use application was abandoned because no acceptable Statement of Use (or valid extension) was filed before the Notice of Allowance deadline expired. The application is dead unless revived within a limited window.
Dec 8, 2025ABN6ABANDONMENT - NO USE STATEMENT FILEDThe intent-to-use application was abandoned because no acceptable Statement of Use (or valid extension) was filed before the Notice of Allowance deadline expired. The application is dead unless revived within a limited window.
May 3, 2025EXRANOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED—
May 2, 2025EX4GSOU EXTENSION 4 GRANTED—
May 2, 2025EXT4SOU EXTENSION 4 FILED—
May 2, 2025EEXTSOU TEAS EXTENSION RECEIVEDThe applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use.
Jan 8, 2025ASGNAUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP—
Nov 1, 2024EXRANOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED—
Nov 1, 2024EX3GSOU EXTENSION 3 GRANTED—
Nov 1, 2024EXT3SOU EXTENSION 3 FILED—
Nov 1, 2024EEXTSOU TEAS EXTENSION RECEIVEDThe applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use.
Apr 27, 2024EXRANOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED—
Apr 26, 2024EX2GSOU EXTENSION 2 GRANTED—
Apr 26, 2024EXT2SOU EXTENSION 2 FILED—
Apr 26, 2024EEXTSOU TEAS EXTENSION RECEIVEDThe applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use.
Nov 4, 2023EXRANOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED—
Nov 2, 2023EX1GSOU EXTENSION 1 GRANTED—
Nov 2, 2023EXT1SOU EXTENSION 1 FILED—
Nov 2, 2023EEXTSOU TEAS EXTENSION RECEIVEDThe applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use.
May 2, 2023NOAMNOA E-MAILED - SOU REQUIRED FROM APPLICANTA Notice of Allowance means your intent-to-use application cleared examination and opposition but is not registered yet. You must file a Statement of Use showing the mark in commerce, or request an extension, before the deadline — usually six months from the notice date.
Mar 7, 2023NPUBOFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED—
Mar 7, 2023PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
Feb 15, 2023NONPNOTIFICATION OF NOTICE OF PUBLICATION E-MAILED—
Jan 31, 2023CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
Jan 18, 2023TEMETEAS/EMAIL CORRESPONDENCE ENTERED—
Jan 17, 2023CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Jan 17, 2023TROATEAS RESPONSE TO OFFICE ACTION RECEIVEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Jul 15, 2022GNRNNOTIFICATION OF NON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Jul 15, 2022GNRTNON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Jul 15, 2022CNRTNON-FINAL ACTION WRITTENA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Jul 8, 2022DOCKASSIGNED TO EXAMINER—
Oct 29, 2021NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED—
Oct 8, 2021NWAPNEW APPLICATION ENTERED—

Frequently asked questions

Related guidance